Provided by Tiger Fintech (Singapore) Pte. Ltd.

Clearmind Medicine, Inc.

1.20
+0.06005.26%
Pre-market: 1.200.00000.00%08:00 EDT
Volume:40.08K
Turnover:46.11K
Market Cap:5.63M
PE:-0.71
High:1.20
Open:1.18
Low:1.10
Close:1.14
Loading ...
Jan 22, 2025

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Dec 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 27, 2024

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Mar 19, 2024

Correspondence

Form CORRESP - Correspondence
Mar 18, 2024

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Feb 14, 2024

Correspondence

Form CORRESP - Correspondence
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 29, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jan 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 27, 2023

Correspondence

Form CORRESP - Correspondence
Sep 14, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Sep 13, 2023

Correspondence

Form CORRESP - Correspondence
Sep 06, 2023

Correspondence

Form CORRESP - Correspondence